Caxton Corp Portfolio Holdings

Caxton Corp has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $18.7 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Xeris Biopharma Holdings, Inc. with a value of $11.5M, Rezolute, Inc. with a value of $5.67M, Spdr S&P 500 ETF Trust with a value of $1.02M, Berkshire Hathaway Inc Class B with a value of $416K, and Compass Therapeutics, Inc. with a value of $43K.

Examining the 13F form we can see an increase of $2.52M in the current position value, from $16.2M to 18.7M.

Caxton Corp is based out at Princeton, NJ

Below you can find more details about Caxton Corp portfolio as well as his latest detailed transactions.